EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Inhibition of TFEB deacetylation in proximal tubular epithelial cells ( TECs ) promotes TFEB activation and alleviates TEC damage in diabetic kidney disease

Xiaoyu Li iD, Yaozhi Zhang iD, Huixia Chen iD, Yang Wu iD, Yongming Chen iD, Siqiao Gong iD, Yonghan Liu iD, Huafeng Liu iD

The FASEB Journal · 2024

DOI: 10.1096/fj.202302634r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Xiaoyu Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Guangdong Provincial Key Laboratory of Autophagy and Major C…. Hauptthemen laut MEDLINE: Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Diabetic Nephropathies, Epithelial Cells, Kidney Tubules, Proximal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Zhanjiang Science and Technology Plan Project, Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-Communicable Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The inhibition of the autophagolysosomal pathway mediated by transcription factor EB (TFEB) inactivation in proximal tubular epithelial cells (TECs) is a key mechanism of TEC injury in diabetic kidney disease (DKD). Acetylation is a novel mechanism that regulates TFEB activity. However, there are currently no studies on whether the adjustment of the acetylation level of TFEB can reduce the damage of diabetic TECs. In this study, we investigated the effect of Trichostatin A (TSA), a typical deacetylase inhibitor, on TFEB activity and damage to TECs in both in vivo and in vitro models of DKD. Here, we show that TSA treatment can alleviate the pathological damage of glomeruli and renal tubules and delay the DKD progression in db/db mice, which is associated with the increased expression of TFEB and its downstream genes. In vitro studies further confirmed that TSA treatment can upregulate the acetylation level of TFEB, promote its nuclear translocation, and activate the expression of its downstream genes, thereby reducing the apoptosis level of TECs. TFEB deletion or HDAC6 knockdown in TECs can counteract the activation effect of TSA on autophagolysosomal pathway. We also found that TFEB enhances the transcription of Tfeb through binding to its promoter and promotes its own expression. Our results, thus, provide a novel therapeutic mechanism for DKD that the alleviation of TEC damage by activating the autophagic lysosomal pathway through upregulating TFEB acetylation can, thus, delay DKD progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsDiabetic NephropathiesEpithelial CellsKidney Tubules, ProximalHydroxamic AcidsHistone Deacetylase InhibitorsAnimalsMiceAcetylationMaleMice, Inbred C57BLAutophagyApoptosis

Stichwörter der Autor:innen

Trichostatin Aacetylationdiabetic kidney diseasetranscription factor EBtubular epithelial cells

Substanzen

Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsTcfeb protein, mousetrichostatin AHydroxamic AcidsHistone Deacetylase Inhibitors

Autor:innen und Institutionen

  • Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Department of Nephrology, Institute…

ORCID-Profile: Xiaoyu Li, Yaozhi Zhang, Huixia Chen, Yang Wu, Yongming Chen, Siqiao Gong, Yonghan Liu, Huafeng Liu

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • Zhanjiang Science and Technology Plan Project
  • Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-Communicable Diseases
  • Discipline construction project of Guangdong Medical University
  • National Clinical Key Specialty Construction Project (Institute of Nephrology, Affiliated Hospital of Guangdong Medical University)
  • National Natural Science Foundation of China

Zitieren

APA

Li, X., Zhang, Y., Chen, H., Wu, Y., Chen, Y., Gong, S., Liu, Y., & Liu, H. (2024). Inhibition of TFEB deacetylation in proximal tubular epithelial cells ( TECs ) promotes TFEB activation and alleviates TEC damage in diabetic kidney disease. The FASEB Journal. https://doi.org/10.1096/fj.202302634r

Vancouver

Li X, Zhang Y, Chen H, Wu Y, Chen Y, Gong S, et al. Inhibition of TFEB deacetylation in proximal tubular epithelial cells ( TECs ) promotes TFEB activation and alleviates TEC damage in diabetic kidney disease. The FASEB Journal. 2024. doi:10.1096/fj.202302634r

BibTeX
@article{Li2024,
  author = {Li, Xiaoyu and Zhang, Yaozhi and Chen, Huixia and Wu, Yang and Chen, Yongming and Gong, Siqiao and Liu, Yonghan and Liu, Huafeng},
  title = {Inhibition of TFEB deacetylation in proximal tubular epithelial cells ( TECs ) promotes TFEB activation and alleviates TEC damage in diabetic kidney disease},
  journal = {The FASEB Journal},
  year = {2024},
  doi = {10.1096/fj.202302634r}
}
Kostenlos starten →